Xerostomia Therapeutics Market 2021-2031: Share
The Xerostomia Therapeutics Market is expected to register a CAGR of 3.6% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The Xerostomia Therapeutics Market report covers analysis by Product (Salivary Stimulants, Salivary Substitutes, Dentifrices); Type (OTC, Prescription), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Xerostomia Therapeutics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Xerostomia Therapeutics Market Segmentation
Product- Salivary Stimulants
- Salivary Substitutes
- Dentifrices
- OTC
- Prescription
Strategic Insights
Xerostomia Therapeutics Market Growth Drivers- Rising Prevalence of Xerostomia:
The growing incidence of xerostomia, especially among the aging population and cancer patients undergoing treatments like radiation, is driving the demand for effective therapeutics.
- Side Effects of Cancer Treatments:
Chemotherapy and head and neck radiation therapies often lead to dry mouth as a side effect, significantly increasing the need for xerostomia treatment options.
- Aging Population:
As the global elderly population increases, the prevalence of conditions leading to xerostomia, such as Sjögren's syndrome and other autoimmune diseases, is also rising, contributing to the market's growth.
- Shift Toward Innovative Treatments:
There is an increasing shift towards innovative, non-invasive treatments, such as oral lubricants, saliva stimulants, and products that enhance salivary gland function.
- Development of Drug-Based Therapies:
Pharmaceutical companies are focusing on developing novel drug-based therapies, including oral tablets and sprays, to stimulate saliva production and alleviate symptoms of xerostomia.
- Integration of Biotechnology in Treatment Options:
Biotechnology advancements are leading to the development of biologic products and regenerative treatments aimed at restoring salivary gland function, offering new solutions for patients.
- Expanding Treatment Options:
Ongoing research into new treatments, including gene therapy and regenerative approaches, offers vast potential for the development of more effective and long-lasting solutions.
- Collaborations and Partnerships:
Collaborations between pharmaceutical companies, biotech firms, and academic institutions can accelerate the development and commercialization of new xerostomia therapies.
- Increase in Clinical Trials and R&D Investment:
With increasing investment in clinical trials and research and development, novel and more effective therapies for xerostomia are expected to enter the market in the coming years.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Xerostomia Therapeutics Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Xerostomia Therapeutics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Xerostomia Therapeutics Market is estimated to witness a CAGR of 3.6% from 2023 to 2031.
The major factors driving the market are: Growing geriatric population, Rising awareness of oral health, Advancements in treatment options
Key future trends in this market are - Expanding Patient Awareness, Natural and Organic Products, Geriatric Population
Key companies of this market are: Acacia Pharma, Pfizer, Inc., GlaxoSmithKline plc, Church & Dwight Co., Inc., Lupin, Sun Pharmaceutical Industries, Ltd., Hikma Pharmaceuticals PLC, Pendopharm, OraCoat, Parnell Pharmaceuticals, Inc.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Xerostomia Therapeutics Market - By Product
1.3.2 Xerostomia Therapeutics Market - By Type
1.3.3 Xerostomia Therapeutics Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. XEROSTOMIA THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. XEROSTOMIA THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. XEROSTOMIA THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. XEROSTOMIA THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. XEROSTOMIA THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. XEROSTOMIA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. SALIVARY STIMULANTS
7.3.1. Overview
7.3.2. Salivary Stimulants Market Forecast and Analysis
7.4. SALIVARY SUBSTITUTES
7.4.1. Overview
7.4.2. Salivary Substitutes Market Forecast and Analysis
7.5. DENTIFRICES
7.5.1. Overview
7.5.2. Dentifrices Market Forecast and Analysis
8. XEROSTOMIA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. OTC
8.3.1. Overview
8.3.2. OTC Market Forecast and Analysis
8.4. PRESCRIPTION.
8.4.1. Overview
8.4.2. Prescription. Market Forecast and Analysis
9. XEROSTOMIA THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Xerostomia Therapeutics Market Overview
9.1.2 North America Xerostomia Therapeutics Market Forecasts and Analysis
9.1.3 North America Xerostomia Therapeutics Market Forecasts and Analysis - By Product
9.1.4 North America Xerostomia Therapeutics Market Forecasts and Analysis - By Type
9.1.5 North America Xerostomia Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Xerostomia Therapeutics Market
9.1.5.1.1 United States Xerostomia Therapeutics Market by Product
9.1.5.1.2 United States Xerostomia Therapeutics Market by Type
9.1.5.2 Canada Xerostomia Therapeutics Market
9.1.5.2.1 Canada Xerostomia Therapeutics Market by Product
9.1.5.2.2 Canada Xerostomia Therapeutics Market by Type
9.1.5.3 Mexico Xerostomia Therapeutics Market
9.1.5.3.1 Mexico Xerostomia Therapeutics Market by Product
9.1.5.3.2 Mexico Xerostomia Therapeutics Market by Type
9.1.5.4 US Xerostomia Therapeutics Market
9.1.5.4.1 US Xerostomia Therapeutics Market by Product
9.1.5.4.2 US Xerostomia Therapeutics Market by Type
9.2. EUROPE
9.2.1 Europe Xerostomia Therapeutics Market Overview
9.2.2 Europe Xerostomia Therapeutics Market Forecasts and Analysis
9.2.3 Europe Xerostomia Therapeutics Market Forecasts and Analysis - By Product
9.2.4 Europe Xerostomia Therapeutics Market Forecasts and Analysis - By Type
9.2.5 Europe Xerostomia Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Xerostomia Therapeutics Market
9.2.5.1.1 Germany Xerostomia Therapeutics Market by Product
9.2.5.1.2 Germany Xerostomia Therapeutics Market by Type
9.2.5.2 France Xerostomia Therapeutics Market
9.2.5.2.1 France Xerostomia Therapeutics Market by Product
9.2.5.2.2 France Xerostomia Therapeutics Market by Type
9.2.5.3 Italy Xerostomia Therapeutics Market
9.2.5.3.1 Italy Xerostomia Therapeutics Market by Product
9.2.5.3.2 Italy Xerostomia Therapeutics Market by Type
9.2.5.4 Spain Xerostomia Therapeutics Market
9.2.5.4.1 Spain Xerostomia Therapeutics Market by Product
9.2.5.4.2 Spain Xerostomia Therapeutics Market by Type
9.2.5.5 United Kingdom Xerostomia Therapeutics Market
9.2.5.5.1 United Kingdom Xerostomia Therapeutics Market by Product
9.2.5.5.2 United Kingdom Xerostomia Therapeutics Market by Type
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Xerostomia Therapeutics Market Overview
9.3.2 Asia-Pacific Xerostomia Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Xerostomia Therapeutics Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Xerostomia Therapeutics Market Forecasts and Analysis - By Type
9.3.5 Asia-Pacific Xerostomia Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Xerostomia Therapeutics Market
9.3.5.1.1 Australia Xerostomia Therapeutics Market by Product
9.3.5.1.2 Australia Xerostomia Therapeutics Market by Type
9.3.5.2 China Xerostomia Therapeutics Market
9.3.5.2.1 China Xerostomia Therapeutics Market by Product
9.3.5.2.2 China Xerostomia Therapeutics Market by Type
9.3.5.3 India Xerostomia Therapeutics Market
9.3.5.3.1 India Xerostomia Therapeutics Market by Product
9.3.5.3.2 India Xerostomia Therapeutics Market by Type
9.3.5.4 Japan Xerostomia Therapeutics Market
9.3.5.4.1 Japan Xerostomia Therapeutics Market by Product
9.3.5.4.2 Japan Xerostomia Therapeutics Market by Type
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Xerostomia Therapeutics Market Overview
9.4.2 Middle East and Africa Xerostomia Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Xerostomia Therapeutics Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Xerostomia Therapeutics Market Forecasts and Analysis - By Type
9.4.5 Middle East and Africa Xerostomia Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Xerostomia Therapeutics Market
9.4.5.1.1 South Africa Xerostomia Therapeutics Market by Product
9.4.5.1.2 South Africa Xerostomia Therapeutics Market by Type
9.4.5.2 Saudi Arabia Xerostomia Therapeutics Market
9.4.5.2.1 Saudi Arabia Xerostomia Therapeutics Market by Product
9.4.5.2.2 Saudi Arabia Xerostomia Therapeutics Market by Type
9.4.5.3 U.A.E Xerostomia Therapeutics Market
9.4.5.3.1 U.A.E Xerostomia Therapeutics Market by Product
9.4.5.3.2 U.A.E Xerostomia Therapeutics Market by Type
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Xerostomia Therapeutics Market Overview
9.5.2 South and Central America Xerostomia Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Xerostomia Therapeutics Market Forecasts and Analysis - By Product
9.5.4 South and Central America Xerostomia Therapeutics Market Forecasts and Analysis - By Type
9.5.5 South and Central America Xerostomia Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Xerostomia Therapeutics Market
9.5.5.1.1 Brazil Xerostomia Therapeutics Market by Product
9.5.5.1.2 Brazil Xerostomia Therapeutics Market by Type
9.5.5.2 Argentina Xerostomia Therapeutics Market
9.5.5.2.1 Argentina Xerostomia Therapeutics Market by Product
9.5.5.2.2 Argentina Xerostomia Therapeutics Market by Type
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. XEROSTOMIA THERAPEUTICS MARKET, KEY COMPANY PROFILES
11.1. ACACIA PHARMA
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. PFIZER, INC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GLAXOSMITHKLINE PLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. CHURCH AND DWIGHT CO., INC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LUPIN
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. SUN PHARMACEUTICAL INDUSTRIES, LTD
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. HIKMA PHARMACEUTICALS PLC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PENDOPHARM
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. ORACOAT
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. PARNELL PHARMACEUTICALS, INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
- Acacia Pharma
- Pfizer, Inc.
- GlaxoSmithKline plc
- Church & Dwight Co. , Inc.
- Lupin
- Sun Pharmaceutical Industries, Ltd.
- Hikma Pharmaceuticals PLC
- Pendopharm
- OraCoat
- Parnell Pharmaceuticals, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For